The p-value (0.059495) is close to (0.05) suggesting a trend towards significance but not meeting it strictly.
← all excerpts
Evaluation of efficacy of GCSF in reducing neutropenia among carcinoma patients undergoing anti-cancer chemotherapy. A prospective cohort study.
1
—
—